Evommune, Inc. — insider transactions

1 transactions on record · EVMN · CIK 2044725

Aggregates

computed from the filings below

Purchases, 12m

1

count of open-market buys

Sales, 12m

0

count of open-market sales

Buy / sell ratio, 12m

—

no sales recorded

Distinct insiders, 12m

1

Bought, 3m

$13.3K

Sold, 3m

$0

Median disclosure lag

2.0 d

trade date to filing date

Largest single trade, 24m

$13.3K

2026-07-08

Director share, 12m

0.0%

of transactions where role is stated

Current run

1 buys

consecutive same-direction transactions

Net 3m flow

$13.3K

purchases minus sales

Total on record

1

Transactions

1 most recent shown

Disclosed	Traded	Lag, d	Insider	Role	Transaction	Shares	Price	Value	Source
2026-07-10	2026-07-08	2	Carver Kyle	Chief Financial Officer	Open market purchase	1,000	$13.26	$13.3K	filing

Source: U.S. Securities and Exchange Commission, EDGAR

Evommune, Inc. insider transactions — 1 filings on record — Tapewire